Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016

    Lugli, A; Kirsch, R; Ajioka, Y; Bosman, F; Cathomas, G; Dawson, H; El Zimaity, H; Fléjou, J. F; Hansen, T. P; Hartmann, A; Kakar, S; Langner, C; Nagtegaal, I; Puppa, G; Riddell, R; Ristimäki, A; Sheahan, K; Smyrk, T; Sugihara, K; Terris, B; Ueno, H; Vieth, M; Zlobec, I; Quirke, P.
    Mod. pathol; 30 (9), 2017
    Tumor budding is a well-established independent prognostic factor in colorectal cancer but a standardized method for its assessment has been lacking. The primary aim of the International Tumor Budding Consensus Conference (ITBCC) was to reach agreement on an international, evidence-based standardized sco...
    Neoplasias Colorrectales/patología, Estadificación de Neoplasias, Invasividad Neoplásica/patología, Biopsia/normas, Valor Predictivo de las Pruebas, Metástasis Linfática/patología
    Texto completo

    SIE, SIES, GITMO revised guidelines for the management offollicular lymphoma

    Zinzani, Pier Luigi; Marchetti, Monia; Billio, Atto; Barosi, Giovanni; Carella, Angelo Michele; Lazzarino, Mario; Martelli, Maurizio; Rambaldi, Alessandro; Rigacci, Luigi; Tarella, Corrado; Vitolo, Umberto; Tura, Sante.
    Am. j. hematol; 90 (1), 2005
    By using the GRADE system, we updated the guidelines for management of follicular cell lymphoma issuedin 2006 from SIE, SIES, and GITMO group. We confirmed our recommendation to frontline chemoimmuno-therapy in patients with Stage III–IV disease and/or high tumor burden. Maintenance rituximab was alsor...
    Anticuerpos Monoclonales, Anticuerpos, Anticuerpos Monoclonales de Origen Murino/uso terapéutico, Antineoplásicos, Esquema de Medicación, Trasplante de Células Madre Hematopoyéticas, Linfoma Folicular/patología, Linfoma/terapia, Estadificación de Neoplasias, Rituximab, Factores de Tiempo
    Texto completo